BioCardia receives Nasdaq notice for trading below $1 minimum bid price requirement

PUBT · 2d ago
BioCardia receives Nasdaq notice for trading below $1 minimum bid price requirement
  • BioCardia received a Nasdaq notice on Aug. 19, 2026 for failing the $1 minimum bid price rule for 30 consecutive sessions.
  • The stock has until Feb. 16, 2027 to regain compliance by closing at $1 or more for 10 consecutive business days.
  • Non-compliance could trigger a delisting process, with a possible second 180-day cure period if listing standards are met.
  • Management is monitoring the share price, with a reverse stock split among potential options to restore compliance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCardia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-028744), on August 21, 2026, and is solely responsible for the information contained therein.